| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.00081 | 1 |